Putnam FL Investment Management Co. Buys New Holdings in Henry Schein, Inc. (HSIC)
Putnam FL Investment Management Co. bought a new position in Henry Schein, Inc. (NASDAQ:HSIC) in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 9,112 shares of the company’s stock, valued at approximately $747,000.
Several other institutional investors have also bought and sold shares of HSIC. Alecta Pensionsforsakring Omsesidigt increased its holdings in shares of Henry Schein by 112.0% in the 3rd quarter. Alecta Pensionsforsakring Omsesidigt now owns 5,313,980 shares of the company’s stock worth $435,693,000 after purchasing an additional 2,806,990 shares in the last quarter. Janus Henderson Group PLC grew its holdings in shares of Henry Schein by 394.1% in the second quarter. Janus Henderson Group PLC now owns 1,465,303 shares of the company’s stock worth $268,173,000 after acquiring an additional 1,168,763 shares during the period. Swedbank grew its holdings in shares of Henry Schein by 84.9% in the third quarter. Swedbank now owns 2,358,594 shares of the company’s stock worth $193,381,000 after acquiring an additional 1,083,115 shares during the period. Bank of New York Mellon Corp grew its holdings in shares of Henry Schein by 102.9% in the third quarter. Bank of New York Mellon Corp now owns 1,529,279 shares of the company’s stock worth $125,387,000 after acquiring an additional 775,483 shares during the period. Finally, Fisher Asset Management LLC grew its holdings in shares of Henry Schein by 99.3% in the third quarter. Fisher Asset Management LLC now owns 844,106 shares of the company’s stock worth $69,208,000 after acquiring an additional 420,637 shares during the period. 53.07% of the stock is owned by institutional investors and hedge funds.
Henry Schein, Inc. (HSIC) traded up $1.54 during midday trading on Friday, reaching $69.51. The company had a trading volume of 4,053,400 shares, compared to its average volume of 1,157,625. The stock has a market capitalization of $10,880.00, a P/E ratio of 19.07, a PEG ratio of 1.91 and a beta of 1.03. The company has a quick ratio of 0.86, a current ratio of 1.55 and a debt-to-equity ratio of 0.30. Henry Schein, Inc. has a 12 month low of $65.28 and a 12 month high of $93.50.
Henry Schein (NASDAQ:HSIC) last released its earnings results on Monday, November 6th. The company reported $0.87 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.90 by ($0.03). The company had revenue of $3.16 billion for the quarter, compared to analysts’ expectations of $3.05 billion. Henry Schein had a net margin of 4.52% and a return on equity of 19.71%. Henry Schein’s revenue for the quarter was up 10.3% on a year-over-year basis. During the same quarter last year, the firm posted $0.84 earnings per share. sell-side analysts anticipate that Henry Schein, Inc. will post 3.6 earnings per share for the current fiscal year.
Henry Schein declared that its Board of Directors has approved a stock buyback plan on Monday, September 18th that allows the company to repurchase $400.00 million in outstanding shares. This repurchase authorization allows the company to purchase up to 6.3% of its stock through open market purchases. Stock repurchase plans are usually a sign that the company’s leadership believes its shares are undervalued.
Several analysts recently commented on the company. Royal Bank Of Canada cut their price objective on Henry Schein from $91.00 to $82.00 and set a “sector perform” rating for the company in a report on Tuesday, November 7th. Jefferies Group LLC reaffirmed a “hold” rating and issued a $89.00 price objective on shares of Henry Schein in a report on Friday, October 20th. Credit Suisse Group reaffirmed a “hold” rating and issued a $87.50 price objective on shares of Henry Schein in a report on Tuesday, August 29th. Leerink Swann reaffirmed a “market perform” rating and issued a $77.00 price objective (down previously from $87.50) on shares of Henry Schein in a report on Tuesday, November 7th. Finally, Morgan Stanley assumed coverage on Henry Schein in a report on Thursday, September 21st. They issued an “equal weight” rating and a $88.00 price objective for the company. Two analysts have rated the stock with a sell rating, eight have given a hold rating and seven have given a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus price target of $89.88.
In other news, SVP Paul Rose sold 2,126 shares of the business’s stock in a transaction dated Wednesday, September 6th. The stock was sold at an average price of $172.51, for a total value of $366,756.26. Following the transaction, the senior vice president now directly owns 17,841 shares in the company, valued at $3,077,750.91. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 1.19% of the stock is currently owned by insiders.
Henry Schein Profile
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.